Introduction
The D52 protein family (Byrne et al., 1996) represents a group of highly conserved polypeptides, and currently consists of the members D52 (Byrne et al., 1995) , D53 (Byrne et al., 1996) , and D54 (Nourse et al. manuscript in preparation), the human homologues of which are predicted to be approximately 50% identical. The ®rst member to be described, human D52 (hD52), was initially identi®ed through cloning of the hD52 cDNA during a dierential screening of a human breast carcinoma cDNA library, with hD52 being found to be overexpressed in approximately 40% of breast carcinomas, speci®cally in the cancer cells (Byrne et al., 1995) . A hD52 cDNA (termed N8) was subsequently identi®ed by dierential display of mRNA from ®broblastic and tumour-derived lung cell lines (Chen et al., 1996) . More recently, D52 cDNAs have been cloned in mouse (Byrne et al., 1996) , rabbit (Parente et al., 1996) and Japanese quail (Proux et al., 1996) . The rabbit D52 homologue CSPP28 (calcium sensitive phosphoprotein of 28 kDa) was identi®ed as being one of several proteins known to be phosphorylated in response to cholinergic stimulation of gastric parietal cells, and it was postulated that CSPP28 may participate in the calcium signalling cascade in a variety of rabbit tissues (Parente et al., 1996) . In the Japanese quail (Coturnix coturnix japonica), a D52 homologue R10 was identi®ed as the cellular sequence to which retroviral sequences were joined in chimeric transcripts ampli®ed from in vitro cultures of proliferating neuroretinal cells infected with RAV-1 (Proux et al., 1996) . Thus, D52 may represent a signalling molecule of a calcium-sensitive signalling pathway mediating or associated with aspects of cellular proliferation. A role for both hD52 and hD53 in, or as markers of cell proliferation was also suggested by the observation that hD52 and hD53 transcript levels were decreased in HL60 and K562 leukaemic cell lines, respectively, when these were cultured in the presence of 12-O-tetradecanoylphorbol-13-acetate (Byrne et al., 1996) .
We (Byrne et al., 1996) and others (Chen et al., 1996; Proux et al., 1996) had predicted the existence of a coiled-coil domain in D52-like molecules, which in turn suggests that their functions involve protein-protein interactions. The predicted coiled-coil domains of D52-like proteins are highly conserved both with respect to their sequences, lengths, and locations within D52-like proteins. That a functional relationship may exist between hD52 and hD53 gene products was indicated by examples of similar regulation of hD52 and hD53 transcript levels in both breast carcinoma and leukaemic cell lines, despite the fact that hD52 and hD53 transcripts derive from separate genes located on independent chromosomes (Byrne et al., 1996) . This suggestion of a functional relationship between hD52 and hD53, combined with the degree of conservation between their predicted coiled-coil domains, and the fact that hD52 and hD53 could be either co-or independently expressed, led us to the hypothesis that hD52 and hD53 proteins may be capable of both homo-and heteromer formation (Byrne et al., 1996) . We have used the yeast two-hybrid system to directly test this hypothesis, and to search for potential interacting proteins in human breast carcinoma cells using a yeast two-hybrid screening approach.
Results

D52-like proteins interact homo-and heteromerically within the yeast two-hybrid system
In order to test whether D52-like proteins interact within the yeast two-hybrid system, the relevant coding sequences (or portions thereof) were subcloned into the yeast two-hybrid vectors pACT2 and/or pAS2-1, such that these sequences were in-frame with those encoding the GAL4 transcriptional activation domain (GAL4-AD), or the DNA-binding domain (GAL4-DB), respectively (see Materials and methods). Proteins fused with the GAL4-AD were referred to as interactors, whereas those fused with the GAL4-DB were referred to as baits. The D52-like proteins tested represent the human and mouse homologues of D52 (hD52 and mD52), hD53, and 3 hD54 isoforms ( Figure  1 ). The existence of multiple hD54 isoforms was predicted from coding sequence dierences identi®ed in hD54 cDNAs (Nourse et al. manuscript in preparation), with hD54 sequences diering with respect to a region encoding a 20 amino acid insertion, ins2 (Figure 1 ). Whereas two hD54 cDNA clones contained the 60 bp sequence encoding ins2 (nucleotides 391 ± 450, GenBank Accession No. AF004430), this was absent from another cDNA clone. A further variation was noted where a 71 bp deletion (nucleotides 380 ± 450, GenBank Accession No. AF004430) was predicted to remove ins2, plus an additional four residues from the translated sequence. This deletion was not produced in-frame, and a truncated product was predicted to result after 42 amino acids (Figure 1 ). We refer to the three isomeric forms of hD54 thus predicted as hD54+ins2, hD54-ins2 and hD54t.
Before proceeding with a testing of interactions, D52-like baits and interactors were individually tested for their inability to activate Y190 reporter gene expression. Y190 yeast strains which had been transfected with individual constructs were grown on either solid SD/7Trp media (for baits) or SD/7Leu media (for interactors) incorporating 0.07 M potassium phosphate pH 7 and 40 mg/ml 5-bromo-4-chloro-3-indoyl-b-D-galactopyranoside (X-gal). After 4 days incubation at 308C, colony phenotypes were compared with that of Y190 yeast transfected with the corresponding vector as a negative control. Excepting the case of Y190 yeast transfected with the hD54t bait, a white colony phenotype was obtained for all Y190 strains tested, indicating that these D52-like baits and interactors were unable to activate the Y190 lacZ reporter gene. However, Y190 yeast transfected with the hD54t bait gave a blue colony phenotype after 2 days incubation at 308C on solid SD/7Trp media containing X-gal (data not shown), indicating that hD54 isoform was unsuitable for further use in the yeast two-hybrid system.
For direct testing of interactions between D52-like fusion proteins, each bait plasmid (pAS2-1hD52, pAS2-1mD52, pAS2-1hD53, pAS2-1hD54+ins2, pAS2-1hD54-ins2, and pAS2-1 as a negative control), was paired with each interactor plasmid (pADGAL4hD52 (see Materials and methods), pACT2-mD52 (1 ± 163) , pACT2hD53, pACT2hD54+ins2, pACT2hD54-ins2, and pACT2 as a negative control), and co-transfected into Y190. Interactions between baits and interactors were assessed by qualitatively and/or quantitatively determining HIS3 and/or lacZ reporter gene activity in Y190 co-transfectants (see Materials and methods). All D52-like fusion proteins tested were found to be capable of both homo-and heteromer formation in the yeast two-hybrid system (Figure 2 , and data not shown). However, the results of both qualitative and quantitative b-galactosidase assays indicated that interactions between dierent pairs of D52-like fusion proteins occurred with dierent strengths. In Y190 co-transfectants bearing Figure 1 Global alignment of D52-like sequences tested in the yeast two-hybrid system, as produced by the programme CLUSTAL (Thompson et al., 1994) . The coiled-coil domain predicted in each D52-like protein is shown in bold. Two alternatively-spliced regions, ins2 and ins3, are indicated, and the hD54t amino acid sequence which shows no similarity to other D52-like sequences (due to a frame-shift in the corresponding cDNA sequence, GenBank accession no. AF004430) is underlined. Numbers refer to sequence positions of the ®rst and last amino acids shown in each line hD53-encoding constructs, the highest b-galactosidase activity level was obtained for the interaction between hD53 fusion proteins (Figure 2 ), indicating that homomeric interactions were preferred. However, in Y190 co-transfectants bearing mD52-or hD52-encoding constructs, homomeric interactions were indicated to be signi®cantly weaker than heteromeric interactions between D52-and hD53 fusion proteins (Figure 2 ). In the cases of Y190 co-transfectants bearing hD54+ins2 or hD54-ins2 constructs, the highest levels of bgalactosidase activity were also noted for heteromeric interactions with hD53 fusion proteins (Figure 2 ).
Interactions between D52-like proteins occur via their predicted coiled-coil domains
In order to test whether the interactions observed between D52-like proteins occurred via their predicted coiled-coil domains, we employed two bait constructs, pAS2-1mD52 (1 ± 95) and pAS2-1mD52 (95 ± 185) . These encode fusion proteins between the GAL4-DB and the Nterminal half of mD52 (which includes the predicted coiled-coil domain at Glu 29 -Leu 71 ), or the C-terminal half of mD52, respectively. These bait constructs, or pAS2-1mD52 as a positive control, were paired with the interactor plasmid pACT2hD53, or pACT2 as a negative control, and co-transfected into Y190 cells, and interactions were qualitatively and/or quantitatively assessed by determining HIS3 and lacZ reporter gene activity (Figure 3 , and data not shown). Similar levels of b-galactosidase activity were obtained in Y190 cells co-transfected with the hD53 interactor and fulllength mD52 or mD52 (1 ± 95) baits, whereas negligible bgalactosidase activity was detected in Y190 cotransfectants bearing the hD53 interactor and mD52 (95 ± 185) bait (Figure 3 ). This indicated that the ®rst 95 amino acids of mD52, which include the predicted coiled-coil domain, were responsible for mediating the interaction observed between the mD52 bait and hD53 (Figures 2 and 3 ).
hD52 and hD53 proteins were identi®ed as potential interactors for hD52 and hD53 baits using yeast twohybrid screening
We chose to construct and screen an expression library using the same human breast carcinoma from which Figure 2 Interactions between D52-like proteins within the yeast two-hybrid system, as measured by quantitative b-galactosidase assays. Bait constructs (or the pAS2-1 vector as a negative control) were paired with interactor constructs (or the pACT2 vector as a negative control), and co-transfected into Y190 cells. Three (or two*) colonies from each co-transfected Y190 strain were cultured in the absence of histidine, and assayed separately for b-galactosidase activity (see Materials and methods). The mean number of bgalactosidase activity units obtained for each co-transfection is presented, + the standard error. To permit comparisons between assays, all values have been related to a mean number of b-galactosidase activity units obtained for three simultaneously-performed, positive control assays (see Materials and methods), which was set to 1000 units Figure 3 Interactions between wild type or truncated mD52 baits and hD53 within the yeast two-hybrid system, as measured by quantitative b-galactosidase assays. Bait constructs were paired with the interactor construct pACT2hD53 (or pACT2 as a negative control), and co-transfected into Y190 cells. Three colonies from each co-transfected Y190 strain were cultured in the absence of histidine, and assayed separately for b-galactosidase activity (see Materials and methods). The mean number of bgalactosidase activity units is presented, + the standard error. Presented values have, in all cases, been standardized to the mean number of b-galactosidase activity units obtained for three simultaneously-performed, positive control assays (see Materials and methods), which was to 1000 units the hD52, hD53 and hD54 cDNAs had been isolated (Byrne et al., 1995 (Byrne et al., , 1996 Nourse et al. manuscript in preparation) . In this way, interacting proteins identi®ed through library screening would be more likely to be co-expressed with D52-like proteins, and thus to represent biological partners for these proteins (Allen et al., 1995) .
Screening approximately 772 200 c.f.u. of the breast carcinoma cDNA expression library in Y190 cells using the full-length hD53 bait (see Materials and methods) resulted in the identi®cation of 8 Y190 colonies which were reproducibly His+ and lacZ+. Of these, 6 colonies contained pAD-GAL4 constructs encoding hD53, one colony contained a pAD-GAL4 construct encoding hD52 (pAD-GAL4hD52) (Table 1) , and the remaining colony contained a`false-positive' interactor (see Materials and methods). All hD53 and hD52 cDNAs included sequence encoding the entire predicted coiled-coil domain (Table 1) .
Screening approximately 1 350 000 c.f.u. of the same expression library in Y190 cells using the full-length hD52 bait identi®ed only one His+ lacZ+ Y190 colony, whose interactor was subsequently indicated to be a false-positive (data not shown). Since this approach did not identify any reproducible interactor for the hD52 bait, we elected to perform a more sensitive screening in Hf7c cells. The Hf7c HIS3 reporter is less`leaky' than the Y190 HIS3 reporter (Feilotter et al., 1994; Durfee et al., 1993) , and the HIS3 competitor 3-amino-1, 2, 4-triazole is therefore not required to be added to selective media to suppress a basal level of HIS3 expression (Feilotter et al., 1994) . Thus, weaker interactions with bait proteins are more likely to be detected (Allen et al., 1995) . Screening approximately 44 000 c.f.u. of the breast carcinoma cDNA expression library in Hf7c cells resulted in a total of 10 His+ colonies. Of these, single colonies contained pAD-GAL4 constructs encoding hD53 and hD52 interactors with complete predicted coiled-coil domains (Table 1) , whereas the remaining eight colonies contained`false-positive' interactors.
Identi®cation of a novel hD53 isoform using yeast twohybrid screening
Of the 7 hD53 cDNAs identi®ed in this study using D52-like baits, the sequence of one (+5) diered signi®cantly from those of the remaining six hD53 cDNAs, and from previously identi®ed D53 cDNA sequences (Byrne et al., 1996 , GenBank accession no. AF004428). The most 5' 59 bp of the +5 cDNA could not be aligned with any other D53 sequence, and predicted a 20 amino acid stretch which showed no similarity to hD53 (Figure 4) . However, the coding sequences and reading frames of +5 and hD53 subsequently became identical for 365 bp, at which point a 100 bp deletion was noted in the +5 cDNA sequence with respect to hD53 (nts 567 ± 666, GenBank accession no. U44427). Since the deletion does not occur in-frame, a truncated product is predicted to result (Figure 4 ). The +5 cDNA does not appear to be full-length, since there is no Met residue in a favourable context for translation initiation within the novel sequence (GenBank accession no. AF004427, Figure 4 ). Thus while it is dicult to predict the size of the novel hD53 isoform, it is predicted to be greater than 144 amino acids in length.
Glutathione S-transferase (GST) pull-down assays indicate homo-and heteromeric interactions between recombinant GST-mD52 protein and in vitro-translated D52-like proteins
In order to examine whether D52-like proteins are able to interact homo-and heteromerically in vitro as well as in vivo, we analysed binding between GST-tagged mD52 protein and in vitro-translated D52-like proteins using a GST pull-down assay system. In vitro translation of mD52 and hD52 coding sequences gave The +5 hD53 cDNA predicts a novel hD53 isoform, and sequence co-ordinates refer to those speci®ed in GenBank accession no. AF004427. c This pAD-GAL4hD52 interactor was used in the direct testing of interactions in the yeast two-hybrid system Figure 4 Alignment of the novel hD53 isoform predicted by the +5 cDNA with hD53. Amino acid sequences present in the +5 isoform which bear no similarity to corresponding hD53 sequences are underlined, whereas the identical coiled-coil domains predicted for each isoform are shown in bold. The alternatively-spliced region ins3 is indicated and shown in bold. Numbers refer to sequence positions of the ®rst and last amino acids shown in each line rise to single 28 kDa 35 S-labelled proteins, whereas in vitro translation of the hD54-ins2 coding sequence gave rise to a 31 kDa 35 S-labelled protein (Figure 5a ). While larger than might be predicted from amino acid sequence data alone, these protein sizes are in agreement with that reported for GSPP28 (Parente et al., 1996) . Recombinant GST-mD52, or GST alone, were produced in the BL21 E. coli strain, and soluble post-induction extracts were incubated with glutathione-agarose. The subsequently bound GST-mD52 or GST was then incubated with in vitro translated proteins, and a large excess of soluble BL21 extract as a complex binding competitor. Following washing of matrices and the elution of bound material, the binding characteristics of in vitro-translated D52-like proteins to GST (Figure 5b and c) or GST-mD52 (Figure 5d and e) could be compared. Autoradiographs (Figure 5c and e) of Coomassie Brilliant Blue-stained gels ( Figure  5b and d) indicated that 35 S-labelled D52-like proteins were only retained on matrices to which GST-mD52 was bound. In vitro-translated proteins were not retained on glutathione-agarose to which GST had been bound, indicating that 35 S-labelled D52-like proteins were unable to bind to either GST or glutathione-agarose.
Discussion
The hypothesis that D52-like proteins are capable of interacting both homo-and heteromerically was initially advanced on the basis of several lines of evidence (Byrne et al., 1996) . Similar coiled-coil domains were predicted in both hD52 and hD53 proteins, and the corresponding genes were observed to be either co-or independently expressed in human cell lines. Moreover, examples of similar regulation of hD52 and hD53 transcript levels in both breast carcinoma and leukaemic cell lines suggested the existence of a functional relationship between hD52 and hD53 (Byrne et al., 1996) . The present study has permitted both the con®rmation of this hypothesis, and its extension to include a third member of the D52 protein family, hD54 (Nourse et al. manuscript in preparation), in that D52-like proteins were found to interact in homo-and heteromeric fashions both in vivo (Figures 2 and 3 ) and in vitro ( Figure 5 ). Using the yeast two-hybrid system, we were able to demonstrate interactions between all D52-like fusion proteins tested which, in most cases, were independent of whether a given D52-like protein was present as a bait or an interactor (Figure 2) . Similarly, screening a human breast carcinoma expression library using both hD53 and hD52 baits identi®ed both homo-and heteromeric interactions between these proteins (Table 1 ). The fact that the breast carcinoma used for the construction of our expression library represented a sample in which D52-like sequences were co-expressed (Byrne et al., 1995 (Byrne et al., , 1996 Nourse et al. manuscript in preparation) indicates furthermore that these interactions may be biologically relevant. Interations between mD52 and hD53 fusion proteins were found to be mediated via mD52 residues 1 ± 95 (Figure 3 ), which include a coiled-coil domain at Glu 29 -Leu 71 (Byrne et al., 1996) . This predicted coiled-coil domain, like those of human D52-like proteins, was scored by the programme Pepcoil as having maximal likelihood of occurring. Indications that hD52 and hD53 coiled-coil domains were also mediating homo-and heteromeric interactions between these proteins derive from the results of yeast two-hybrid screenings, where all hD52 and hD53 interactors identi®ed contained sequences encoding entire coiled-coil domains (Table 1) .
Results from both direct testing of interactions between D52-like fusion proteins and yeast two-hybrid screenings have suggested that not all interactions between D52-like proteins occur with the same strengths. In particular, homomeric interactions were indicated to be preferred by the hD53 bait ( Figure 2 and Table 1 ), whereas heteromeric interactions with hD53 fusion proteins were preferred by the D52 and hD54 proteins tested (Figure 2 ). However, a comparison of interactions between D52-like proteins and the hD54 isoforms hD54+ins2 or hD54-ins2 indicated that the presence or absence of ins2 did not signi®cantly aect the interaction preferences of hD54 baits or (Figure 2) . Thus, the presence or absence of ins2 24 amino acids C-terminal of the hD54 coiled-coil domain does not appear to obviously aect this domain's function. The signi®cance of ins2 in hD54 proteins is however unclear, as no homology can be identi®ed between the 20 amino acids comprising ins2, and the sequences of other known proteins.
The cloning of an alternatively-spliced form of hD53 during a yeast two-hybrid screening using the hD53 bait has also provided further evidence that multiple protein isoforms may be produced from D52-like genes (Proux et al., 1996; Nourse et al. manuscript in preparation) . The +5 hD53 cDNA identi®ed in the present study predicts a C-terminally truncated hD53 protein as a result of a 100 bp out-of-frame deletion removing hD53 nts 567 ± 666 (GenBank accession no. U44427). The resulting truncation occurs three residues after Met 128 , which represents the ®rst residue of an alternatively-spliced 13 amino acid region (Met 128 -Ala 140 ) referred to as ins3 (Figure 4 ; Nourse et al. in preparation). A 23 amino acid ins3-like sequence is also predicted in a quail D52 homologue, R10 (Proux et al., 1996) . We had previously sequenced a partial hD53 cDNA (clone 83289; GenBank accession nos. T68402 and U44429) isolated by the IMAGE consortium (Lennon et al., 1996) which contained the same 100 bp deletion now noted in the +5 cDNA (Byrne et al., 1996) . As this deletion was only observed in a single cDNA at this time, we could not exclude the possibility that it had arisen through a cloning artefact. However, four additional expressed sequence tags (ESTs) now also show identical 100 bp deletions (GenBank accession nos. AA055718, AA066421, W11611 and W14257), and another EST (GenBank accession no. W69680) shows a smaller deletion of 61 bp (hD53 nts 606 ± 666, GenBank accession no. U44427) which predicts a similar truncation occurring three residues after Met 141 , immediately after ins3 (Figure 4) . That alternative splicing mechanisms appear to regulate the presence or absence of the Cterminal portion of hD53 (and particularly, the presence or absence of ins3) suggests that these regions have roles in modulating D53 function.
While single putative D52 homologues have thus far been indicated in C. elegans (EMBL Accession No. Z68105; Wilson et al., 1994) , and D. melanogaster (GenBank Accession Nos. AA263893, AA390326 and AA392910), three human D52-like genes have been identi®ed, and analyses of mammalian ESTs identify sequences (GenBank Accession Nos. W50222, W49042 and AA130196) which predict the existence of additional mammalian D52-like genes. Since RNAs deriving from those D52-like genes thus far cloned appear to be alternatively spliced (Proux et al., 1996; Nourse et al. manuscript in preparation) , a signi®cant number of D52-like proteins may thus exist. This, combined with the fact that in the present study, each D52-like protein tested could interact with every other D52-like protein examined, indicates a potentially rich array of interactions between D52-like proteins, depending upon the number of individual D52-like genes and isoforms expressed in a particular cell type. However, despite extensive screening of a human breast carcinoma yeast two-hybrid expression library in both Y190 and Hf7c yeast strains using dierent full-length and/or truncated D52-like baits, no other partners were identi®ed for D52-like proteins. While nonetheless indicating that interactions between D52-like proteins are highly speci®c, additional factors may have contributed towards this result. Firstly, technical limitations associated with the yeast two-hybrid system (Allen et al., 1995) may have prevented the demonstration of interactions between D52-like baits and other interactor types. Secondly, it may be that interactions between D52-like proteins and other partners are too weak and/or transient to be detected using the twohybrid system. In the present study, screening sensitivity was maximised by performing two-hybrid screenings in both Hf7c and Y190 strains with the hD52 bait. That the screening in Hf7c cells was more sensitive was indicated by the fact that interactions between the hD52 bait and hD52 or hD53 interactors were only identi®ed in Hf7c cells, despite the fact that a signi®cantly greater proportion of the breast carcinoma library was screened in Y190 cells. Similarly, the number of false-positives obtained in Hf7c cells compared with that obtained in Y190 cells also attests to the sensitivity of the Hf7c HIS3 reporter (Feilotter et al., 1994) . However, since two-hybrid systems have been reported to be inherently more sensitive than other methods of identifying proteinprotein interactions (Allen et al., 1995) , proteins which interact either more weakly and/or transiently with D52-like proteins than D52-like proteins themselves may be dicult to identify using other methodologies. Finally, it is possible that additional partners exist for D52-like proteins in other tissues, but that these are either of low abundance, or not expressed, in breast carcinoma.
The CSPP28 and R10 molecules, which represent D52 homologues in rabbit and quail, respectively, have been implicated in calcium-mediated signal transduction processes (Parente et al., 1996) and the control of cellular proliferation (Proux et al., 1996) . The interactions between D52-like molecules demonstrated in the present study may be integral to the roles of D52-like proteins in these cellular processes, Proux et al. (1996) having also demonstrated homomeric interactions between epitope-tagged and untagged R10 proteins. The functional importance of interactions between D52-like molecules is further supported by the prediction that increased expression of D52-like genes, such as reported for hD52 in a proportion of human breast carcinomas (Byrne et al., 1995) , might be predicted to increase cellular concentrations of the corresponding protein, and thus the proportion of that protein found in homo-and/or heteromeric complexes. Thus, if increased hD52 gene expression promotes breast cancer cell proliferation, it might be predicted that the (more) active form of hD52 in this process is that which is bound to hD52, or other D52-like proteins.
Materials and methods
Yeast strains and media
Yeast cultures were grown at 308C in standard liquid or solid media, based upon either rich YPD media (2% bactopeptone, 1% yeast extract, 2% dextrose), or minimal SD medium (0.67% yeast nitrogen base without amino acids, 2% dextrose, with appropriate amino acid supplements). The S. cerevisiae strain Y190 (Clontech) was used for direct testing of interactions, whereas Y190 and Hf7c (Feilotter et al., 1994) strains were used for expression library screenings.
Plasmid constructions for the yeast two-hybrid system
Constructs for use in the yeast two-hybrid system were made using the pAS2-1 and pACT2 vectors (Clontech). The pAS2-1 vector contains the selectable marker TRP1 and permits the expression of fusion proteins with the GAL4 (1 ± 147) DNA-binding domain, whereas pACT2 contains the selectable marker LEU2, and permits the expression of fusion proteins with the GAL4 (768 ± 881) activation domain. The following pAS2-1 and pACT2 constructs were made by subcloning hD52-like coding sequences (or portions thereof) in-frame using internal restriction sites, and in some cases, those of the original pBS SK7 multiple cloning sites: pAS2-1hD52, a PstI-NsiI fragment comprising nts 64 ± 719 of hD52, and thus including the entire hD52 coding region (Byrne et al., 1995) , was subcloned into the PstI site of pAS2-1; pAS2-1mD52, a PstI ± PstI fragment including nts 1 ± 832 of mD52, and thus the entire mD52 coding region (Byrne et al., 1996) , was subcloned into the PstI site of pAS2-1; pAS2-1hD53, an NcoI ± SalI fragment including nts 180 ± 1347 of hD53, and thus the entire hD53 coding region (Byrne et al., 1996) , was subcloned into the NcoI and SalI sites of pAS2-1; pAS2-1mD52 (1 ± 95) , a PstI ± NsiI fragment including nts 1 ± 306 of mD52, and thus the region encoding amino acids 1 ± 95 of mD52 was subcloned into the PstI site of pAS2-1; pAS2-1mD52 (95 ± 185) , a NsiI ± NsiI fragment including nts 307 ± 787 of mD52, and thus the region encoding amino acids 95 ± 185 of mD52 was subcloned into the PstI site of pAS2-1; pACT2mD52 (1 ± 163) , an EcoRI ± EcoRI fragment including nts 1 ± 507 of mD52, and thus the region encoding amino acids 1 ± 163 of mD52 was subcloned into the EcoRI site of pACT2; and pACT2hD53, an NcoI ± XhoI fragment including nts 180 ± 1347 of hD53, and thus the entire hD53 coding region was subcloned into the NcoI and XhoI sites of pACT2. In the case of the hD52 cDNA (Byrne et al., 1995) , suitable restriction sites for use with the pACT2 vector were absent, and thus a pAD-GAL4hD52 plasmid isolated through yeast two-hybrid screening (see below, Table 1 ) was used for the direct testing of interactions. In the case of hD54 cDNAs encoding the three hD54 isoforms hD54+ins2, hD54-ins2 and hD54t (Nourse et al. manuscript in preparation, GenBank accession no. AF004430), suitable internal restriction sites for both pAS2-1 and pACT2 vectors were absent, and thus coding sequences were PCRampli®ed using the primers 5'-CG CAT GCC ATG -GAC TCC GCC GGC-3' and 5'-TCC CCC GGG GGA-TTA GAA AGG TGC GGG ATC-3'. These PCR primers permitted ampli®cation of sequences including full-length hD54 coding regions, the conversion of a 5' cryptic NcoI site to a full NcoI site, and the introduction of a 3' SmaI site. Resulting PCR products were digested with NcoI and SmaI, and subcloned into the corresponding restriction sites of pACT2 and/or pAS2-1 vectors. This approach resulted in the pAS2-1hD54+ins2, pAS2-1hD54-ins2, pAS2-1hD54t, pACT2hD54+ins2, pACT2hD54-ins2 constructs.
Expression cDNA library construction
A human breast carcinoma cDNA library was constructed in the HybriZAP vector using reagents and instructions supplied by the manufacturer (Stratagene). This vector permits the construction of l bacteriophage cDNA libraries which can be converted to plasmid libraries in the pAD-GAL4 vector by in vivo excision. The pAD-GAL4 vector contains the selectable LEU marker and permits the expression of GAL4 (761 ± 881) activation domain fusion proteins. Brie¯y, 5 mg poly(A) + RNA from a primary in®ltrating ductal breast carcinoma (Byrne et al., 1995) was primed using an oligodT linker-primer incorporating a XhoI site, and reverse-transcribed using MMLV-RT. EcoRI adaptors were ligated and the resulting XhoIdigested inserts were ligated into prepared HybriZAP vector arms. This resulted in approximately 5 6 10 6 p.f.u. which were ampli®ed once on an XL1 Blue MRF' host. An aliquot of the l bacteriophage library (5 6 10 9 p.f.u.) was rescued using in vivo excision in the form of pAD-GAL4 phagemids in a SOLR host, according to the manufacturer's instructions (Stratagene). Plasmid DNA for library screenings was directly isolated from approximately 50 6 10 6 c.f.u. grown on 128 large LB agar plates incorporating 100 mg/ml ampicillin, and puri®ed using Qiagen 500 columns. Over 90% of pAD-GAL4 plasmids were found to contain inserts, with the average insert length being 1.1 kb.
Yeast two-hybrid system
For the direct testing of interactions, paired baits (pAS2-1 constructs) and interactors (pACT2 or pAD-GAL4 constructs) were transfected into the Y190 yeast strain according to the supplier's instructions (Clontech), with cotransfectants being initially selected on solid SD media lacking Trp and Leu (SD/7Trp-Leu). Interactions between baits and interactors were assessed by qualitatively and/or quantitatively determining HIS3 and lacZ reporter gene activity in Y190 co-transfectants. Reporter gene activities were assessed qualitatively by observing the growth and colour development of Y190 co-transfectants on solid SD/ 7His-Trp-Leu incorporating 0.07 M potassium phosphate pH 7, 35 mM 3-AT, and 40 mg/ml X-gal. For quantitative assessment of interactions, b-galactosidase activity was measured using the substrate o-nitrophenyl b-D-galactopyranoside (ONPG) in liquid cultures (SD/7His-Trp-Leu +35 mM 3-AT) of Y190 co-transfectants. As a positive control for each assay, and to permit the comparison of results obtained in dierent assays, b-galactosidase activity was also measured in liquid cultures (SD/7Leu) of Y190 transfected with the GAL4-encoding construct pCL1 (Clontech). For both qualitative and quantitative assays, negative controls were supplied by Y190 co-transfectants in which each bait or interactor had been paired with the opposing empty vector.
Yeast two-hybrid screening
Bait (pAS2-1hD53, or pAS2-1hD52 and human breast carcinoma pAD-GAL4 library plasmids were transfected either sequentially or simultaneously into Y190 or Hf7c strains. Transformants were plated onto solid SD/7His-Trp-Leu (incorporating 35 mM 3-AT in the case of Y190 transformants) and incubated for up to 14 days at 308C. After 3 initial days of growth, plates were inspected daily, and His+ colonies were transferred to SD/7His-TrpLeu+0.07 M potassium phosphate pH 7+40 mg/ml X-gal plates which incorporated 35 mM 3-AT in the case of Y190 co-transformants. Colonies which remained His+, and in the case of Y190 co-transformants were also lacZ+, were re-streaked onto fresh plates to check that all colonies were of uniform phenotype. After 6 days incubation at 308C, yeast colonies were directly harvested, and plasmid DNA was isolated and used to transfect XL1 blue. Mini-preparations of plasmid DNA were performed for at least ®ve XL1 Blue colonies per transfection, with the results of restriction digests dierentiating potential interactors from bait plasmids.
Potential interactors were re-transfected into the yeast strain used in library screening, with the relevant bait, or the pAS2-1 vector as a negative control. Phenotypes of resulting co-transfectants were assayed quantitatively and/ or qualitatively as described above. Where retransfection of an interactor did not reproduce the phenotype originally observed during library screening, the interactor was termed a`false-positive'.
Plasmid constructions for in vitro transcription/translation and GST-pull down assays Constructs for in vitro transcription/translation were made using the pTL1 vector, a derivative of pSG5 (Green et al., 1988) , which permits in vitro transcription from the T7 promoter. The following pTL1 constructs were made by subcloning hD52-like coding sequences with¯anking 5'-and 3'-UTR regions using internal restriction sites, and in some cases, those of the original pBS SK7 multiple cloning sites: pTL1hD52, a BamHI ± BglII fragment including nts 25 ± 972 of hD52 was subcloned into the BamHI site of pTL1; pTL1mD52, a PstI fragment including nts 1 ± 832 of mD52 was subcloned into the PstI site of pTL1; and pTL1hD54-ins2, a XhoI ± PstI fragment including nts 51 ± 662 of hD54-ins2 was subcloned into the XhoI and PstI sites of pTL1. A construct allowing prokaryotic expression of N-terminally GST-tagged mD52 protein was made using the pGEX3X-6His vector, representing a modi®ed form of pGEX3X (Pharmacia). NheI and XbaI restriction sites were introduced into the mD52 coding sequence using site-directed mutagenesis (Kunkel et al., 1987; Ausubel et al., 1997) and the oligonucleotide primers 5'-G CGG GAG CGA GGT-GGC GCT AGC ATG GAC CGC GGC GAG C-3' and 5'-G ATG ACA GAG AGC CCC TCT AGA GCC GAC-CTG TGT CCT G-3', which permitted subcloning of the full-length mD52 coding sequence.
In vitro transcription/translation
Coupled in vitro transcription and translation of D52-like proteins was performed using the TNT T7 wheat germ lysate system (Promega Corp.) according to the manufacturer's instructions. Brie¯y, 0.5 mg linearized plasmid DNA was included in a 25 ml reaction volume with 2 ml translation grade 35 S-Methionine (Amersham Corp.) and incubated at 308C for 90 min. Protein product sizes were veri®ed by electrophoresing 2.5 ml of each reaction through a 10% denaturing polyacrylamide gel which was then ®xed, dried, and exposed to autoradiographic ®lm (BioMax, Kodak) for 3 days at 7808C.
